A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples